Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy
Author:
Publisher
Informa UK Limited
Subject
Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science
Reference77 articles.
1. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer
3. A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy
4. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles
5. PEGylated Polydopamine Nanoparticles Incorporated with Indocyanine Green and Doxorubicin for Magnetically Guided Multimodal Cancer Therapy Triggered by Near-Infrared Light
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo;Drug Delivery and Translational Research;2023-12-31
2. Self-driven bioactive hybrids co-deliver doxorubicin and indocyanine green nanoparticles for chemo/photothermal therapy of breast cancer;Biomedicine & Pharmacotherapy;2023-12
3. Targeted Co-Delivery of FOXM1 Aptamer and DOX By Nucleolin Aptamer-Functionalized pH-Responsive Biocompatible Nanodelivery System to Enhance Therapeutic Efficacy Against Breast Cancer: In Vitro and In Vivo;2023-10-06
4. Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics;Bioengineering;2023-06-25
5. In Vivo Imaging Guided GMBP1 Modified Nanoplatform for Real Time Monitoring and Photothermal Therapy of Multidrug Resistance in Gastric Cancer;Journal of Biomedical Nanotechnology;2023-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3